Our Mission & Credo

Our Mission

To develop and offer pharmaceutical products that meaningfully benefit patients around the world, with a commitment to advancing patient care through transdermal drug delivery.

 

Our Credo

Graphic of Noven Credo

 

Our Quality Policy

Noven is committed to providing safe and effective quality products to our patients by complying with all regulatory requirements for the design, development, qualification, manufacture, testing, and distribution of products, and by continuously improving the reliability and quality of our products, processes, and systems.

Fast Facts

Core Business:
Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:
1987

Employees:
Over 300

Chairman &
Chief Executive Officer:
Dr. Naruhito Higo

Media, General Business
& Other Inquiries:
CorporateAffairs@noven.com

Partnering and Other Business Development Opportunities
Tel: 551-233-2700
BusDev@noven.com

Employment Inquiries:
Marilyn Reynaldo
Associate Director –
Talent Acquisition
mreynaldo@noven.com

Community Support:
Corporate Social Responsibility

Affiliated Companies:
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.

Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.

Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.